Drug Development

Listings
  • Anti-TPBG (clone A1)-SMCC-DMA ADC

    Anti-TPBG (clone A1)-SMCC-DMA ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    http://science-marketplace.org/services/drug-development_1/anti-tpbg-clone-a1-smcc-dma-adc_i3004 This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A1) conjugated via a SMCC linker to DMA. The DMA is targeted to TPBG-positive ca...

  • Anti-TPBG (clone A1)-Mc-MMAD ADC

    Anti-TPBG (clone A1)-Mc-MMAD ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tpbg-100.htm This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A1) conjugated via a Mc linker to MMAD. The MMAD is targeted to TPBG-positive cancers by immunerecognition and delivered...

  • Anti-TPBG (clone A1)-VC-MMAD ADC

    Anti-TPBG (clone A1)-VC-MMAD ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tpbg-100.htm This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A1) conjugated via a VC linker to MMAD. The MMAD is targeted to TPBG-positive cancers by immunerecognition and delivered...

  • Anti-TPBG (clone A1)-VC-MMAE ADC

    Anti-TPBG (clone A1)-VC-MMAE ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tpbg-100.htm This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A1) conjugated via a VC linker to MMAE. The MMAE is targeted to TPBG-positive cancers by immunerecognition and delivered...

  • Anti-TPBG (clone A1)-Mc-MMAF ADC

    Anti-TPBG (clone A1)-Mc-MMAF ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tpbg-100.htm This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A1) conjugated via a Mc linker to MMAF. The MMAF is targeted to TPBG-positive cancers by immunerecognition and delivered...

  • Anti-TNFRSF8 (cAC10)-Mc-VC-PABC-MMAE ADC

    Anti-TNFRSF8 (cAC10)-Mc-VC-PABC-MMAE ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cAC10 ) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and deli...

  • Anti-TNFRSF8 (Brentuximab)-VC-PABC-MMAE ADC

    Anti-TNFRSF8 (Brentuximab)-VC-PABC-MMAE ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody conjugated via a VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into c...

  • Anti-TNFRSF8 (cAC10)-VC-MMAE ADC

    Anti-TNFRSF8 (cAC10)-VC-MMAE ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cAC10)conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into...

  • Anti-TNFRSF8 (Brentuximab)-VC-PAB-MMAE ADC

    Anti-TNFRSF8 (Brentuximab)-VC-PAB-MMAE ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an Anti-TNFRSF8 antibody (Brentuximab) conjugated via a VC-PAB linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into...

  • Anti-TNFRSF8 (cAC10)-DIBO-doxorubicin ADC

    Anti-TNFRSF8 (cAC10)-DIBO-doxorubicin ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cAC10) conjugated via a DIBO linker to a doxorubicin. The doxorubicin is targeted to certain cancers by immunerecognition...

  • Anti-CD30 receptorc (cAC10)-Mc-VC-PABC-MMAF ADC

    Anti-CD30 receptorc (cAC10)-Mc-VC-PABC-MMAF ADC

    Drug Development Shirley (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cAC10) conjugated via a Mc-VC-PABC linker to a MMAF. The MMAF is targeted to certain cancers by immunerecognition and del...

  • Anti-TNFRSF8  (cAC10)-Mc-MMAF ADC

    Anti-TNFRSF8 (cAC10)-Mc-MMAF ADC

    Drug Development New York (New York) January 18, 2018 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cAC10) conjugated via a MC linker to a MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered i...